(2-Aminopyrimidin-5-yl)boronic acid → HCID 73335893, compound

HRID 925774Notes

Reaction equation

HRID 925774 reaction equation
Br[C:2]1[C:10]2[N:9]3[CH2:11][CH2:12][NH:13][C:14](=[O:15])[C:8]3=[C:7]([CH3:16])[C:6]=2[CH:5]=[C:4]([F:17])[CH:3]=1.[NH2:18][C:19]1[N:24]=[CH:23][C:22](B(O)O)=[CH:21][N:20]=1>>[NH2:18][C:19]1[N:24]=[CH:23][C:22]([C:2]2[C:10]3[N:9]4[CH2:11][CH2:12][NH:13][C:14](=[O:15])[C:8]4=[C:7]([CH3:16])[C:6]=3[CH:5]=[C:4]([F:17])[CH:3]=2)=[CH:21][N:20]=1

Participants

3

Procedure

The title compound, white solid (20 mg, 26%), MS (ISP) m/z=312.5 [(M+H)+], mp 310° C., was prepared in accordance with the general method of example 1 from 6-bromo-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one (intermediate 14) (74.3 mg, 0.25 mmol) and commercially available 2-amino-pyrimidin-5-ylboronic acid (45.1 mg, 0.325 mmol).

Sources & evidence

ORD record
ord-2002080df91242e9a01f34eae0a49bf0
Source dataset
uspto-grants-2016_03
Patent number
US09284321B2

Reaction notes

Loading…